Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $27.1B
1-Year Return 23.24%
This Quarter Return
-7.87%
1 Year Return
+23.24%
3 Year Return
+64.59%
5 Year Return
+118.48%
10 Year Return
+210.79%
AUM
$12B
AUM Growth
-$1.05B
Cap. Flow
-$100M
Cap. Flow %
-0.83%
Top 10 Hldgs %
34.84%
Holding
1,453
New
30
Increased
610
Reduced
359
Closed
38

Sector Composition

1 Real Estate 59.2%
2 Technology 9.45%
3 Healthcare 4.32%
4 Consumer Discretionary 4.16%
5 Financials 4.02%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CTMX icon
1326
CytomX Therapeutics
CTMX
$376M
$0 ﹤0.01%
102
CVNA icon
1327
Carvana
CVNA
$50.9B
-4,864
Closed -$110K
DKNG icon
1328
DraftKings
DKNG
$23.1B
-19,328
Closed -$226K
DTIL icon
1329
Precision BioSciences
DTIL
$59.8M
$0 ﹤0.01%
7
EDU icon
1330
New Oriental
EDU
$7.98B
-13,700
Closed -$279K
HOWL icon
1331
Werewolf Therapeutics
HOWL
$61.7M
$0 ﹤0.01%
80
IMA
1332
ImageneBio, Inc. Common Stock
IMA
$89M
$0 ﹤0.01%
9
IMUX icon
1333
Immunic
IMUX
$75.1M
$0 ﹤0.01%
39
KMDA icon
1334
Kamada
KMDA
$411M
$0 ﹤0.01%
84
KRRO icon
1335
Korro Bio
KRRO
$312M
$0 ﹤0.01%
1
LRMR icon
1336
Larimar Therapeutics
LRMR
$337M
$0 ﹤0.01%
29
LXP.PRC icon
1337
LXP Industrial Trust 6.5% Series C Cumulative Convertible Preferred Stock
LXP.PRC
$91.1M
-1,543
Closed -$80K
MGA icon
1338
Magna International
MGA
$12.9B
-3,309
Closed -$182K
NGNE icon
1339
Neurogene
NGNE
$285M
$0 ﹤0.01%
4
NRXP icon
1340
NRX Pharmaceuticals
NRXP
$65.4M
$0 ﹤0.01%
17
NVVE icon
1341
Nuvve Holding Corp
NVVE
$4.21M
-15
Closed -$28K
NXTC icon
1342
NextCure
NXTC
$13M
$0 ﹤0.01%
4
OLMA icon
1343
Olema Pharmaceuticals
OLMA
$570M
$0 ﹤0.01%
118
ORIC icon
1344
Oric Pharmaceuticals
ORIC
$1.06B
$0 ﹤0.01%
135
OVID icon
1345
Ovid Therapeutics
OVID
$87.5M
$0 ﹤0.01%
119
PASG icon
1346
Passage Bio
PASG
$22.8M
$0 ﹤0.01%
9
PBYI icon
1347
Puma Biotechnology
PBYI
$253M
$0 ﹤0.01%
87
PENN icon
1348
PENN Entertainment
PENN
$2.99B
-1,848
Closed -$56K
PRAX icon
1349
Praxis Precision Medicines
PRAX
$986M
$0 ﹤0.01%
9
PRQR icon
1350
ProQR Therapeutics
PRQR
$258M
$0 ﹤0.01%
208